Sovaprevir

Sovaprevir
Systematic (IUPAC) name

(4R)-N-{(1R,2S)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-vinylcyclopropyl}-1-{(2S)-3,3-dimethyl-2-[2-oxo-2-(1-piperidinyl)ethyl]butanoyl}-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-L-prolinamide
Clinical data
Legal status	Investigational
Identifiers
CAS Number	1001667-23-7
PubChem	CID 53362096
ChemSpider	28529313
Synonyms	ACH-1625
Chemical data
Formula	C₄₃H₅₃N₅O₈S
Molar mass	799.98 g/mol
SMILES CC(C)(C)[C@H](CC(=O)N1CCCCC1)C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)Oc5cc(nc6c5ccc(c6)OC)c7ccccc7
InChI InChI=1S/C43H53N5O8S/c1-6-28-25-43(28,41(52)46-57(53,54)31-16-17-31)45-39(50)36-22-30(26-48(36)40(51)33(42(2,3)4)23-38(49)47-19-11-8-12-20-47)56-37-24-34(27-13-9-7-10-14-27)44-35-21-29(55-5)15-18-32(35)37/h6-7,9-10,13-15,18,21,24,28,30-31,33,36H,1,8,11-12,16-17,19-20,22-23,25-26H2,2-5H3,(H,45,50)(H,46,52)/t28-,30-,33-,36+,43-/m1/s1 Key:MHFMTUBUVQZIRE-WINRQGAFSA-N

Sovaprevir (ACH-1625) is an experimental drug designed to treat the hepatitis C virus. It is under development by Achillion Pharmaceuticals.

Sovaprevir received Fast Track status from the U.S. Food and Drug Administration (FDA) in 2012.^[1]

References

↑ Sovaprevir HCV NS3/4A Protease Inhibitor

External links

Achillion Provides Pipeline Update

This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.